ENDRA Life Sciences Balance Sheet (2016-2026) | NDRA

Balance Sheet Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)
14.04M11.79M9.46M7.13M11.28M8.02M4.89M2.36M4.82M3.33M2.83M1.13M6.40M4.75M3.23M2.06M1.81M0.79M0.76M0.36M
Cash & Current Investments (Quarter)
14.04M11.79M9.46M7.13M11.28M8.02M4.89M2.36M4.82M3.33M2.83M1.13M6.40M4.75M3.23M2.06M1.81M0.79M0.76M0.36M
Receivables - Net (Quarter)
Receivables (Quarter)
Inventory (Quarter)
1.32M1.50M1.28M1.93M2.37M2.63M2.64M2.74M2.76M2.76M2.62M2.71M2.71M2.71M
Prepaid Assets (Quarter)
0.97M1.18M1.35M1.06M0.83M0.91M0.49M0.43M0.51M0.31M0.20M0.14M0.31M0.22M0.20M0.12M0.04M0.25M0.21M0.18M
Current Assets (Quarter)
16.34M14.47M12.09M10.12M14.49M11.56M5.38M5.52M8.08M6.40M3.03M1.27M6.71M4.96M3.43M2.18M1.85M1.05M0.97M0.54M
Non-Current Assets
Construction in Progress (Quarter)
0.11M0.11M0.14M0.14M0.14M0.14M0.14M0.14M0.13M0.13M0.13M0.13M
Property, Plant & Equipment (Net) (Quarter)
0.19M0.16M0.13M0.20M0.24M0.23M0.24M0.23M0.19M0.16M0.11M0.11M0.09M0.08M0.07M0.06M0.06M0.05M0.04M0.03M
Long-Term Deferred Tax (Quarter)
13.83M18.53M21.16M
Other Non-Current Assets (Quarter)
0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.53M0.01M0.01M0.65M0.65M0.01M0.37M0.01M0.37M0.37M0.01M0.01M
Non-Current Assets (Quarter)
0.90M0.84M0.78M0.82M0.82M0.78M3.89M1.14M1.16M1.20M3.72M3.79M3.73M3.42M1.02M0.99M0.95M0.92M2.89M2.90M
Assets (Quarter)
17.24M15.31M12.87M10.94M15.31M12.34M9.27M6.65M9.24M7.60M6.75M5.06M10.44M8.38M4.45M3.17M2.81M1.96M3.85M3.44M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
1.51M1.45M1.41M1.22M1.36M1.56M1.52M1.65M1.84M1.97M0.70M1.04M1.17M0.63M0.51M0.44M0.45M0.67M0.62M0.70M
Notes Payables (Quarter)
0.03M0.03M0.03M0.03M
Payables (Quarter)
1.51M1.45M1.41M1.22M1.36M1.56M1.55M1.65M1.87M2.00M0.73M1.04M1.17M0.63M0.51M0.44M0.45M0.67M0.62M0.70M
Accumulated Expenses (Quarter)
0.20M0.10M0.15M0.21M0.16M0.06M0.22M0.20M0.27M0.15M0.27M0.33M0.13M0.06M0.12M0.11M
Short term Debt (Quarter)
0.03M0.03M0.03M0.03M
Current Leases (Quarter)
0.12M0.13M0.13M0.14M0.14M0.15M0.15M0.16M0.16M0.17M0.17M0.18M0.18M0.19M0.10M0.13M0.13M0.13M0.13M0.13M
Current Deferred Revenue (Quarter)
0.91M0.80M0.39M0.33M
Total Current Liabilities (Quarter)
1.64M1.58M1.54M1.36M1.50M1.71M1.70M1.83M2.03M2.17M0.90M1.22M1.35M0.81M0.61M0.57M0.58M0.80M0.75M0.84M
Non-Current Liabilities
Non-Current Debt (Quarter)
0.03M0.03M0.03M0.03M0.03M0.03M
Convertible Debt (Quarter)
Operating Leases (Quarter)
0.71M0.68M0.65M0.62M0.59M0.55M0.52M0.32M0.44M0.24M0.19M0.15M0.28M0.05M0.58M0.46M0.56M0.53M0.36M0.33M
Other Non-Current Liabilities (Quarter)
0.80M0.60M0.48M0.49M
Total Non-Current Liabilities (Quarter)
0.37M0.24M0.19M0.15M0.10M0.96M1.29M0.85M0.76M0.99M0.84M0.82M
Total Liabilities (Quarter)
2.25M2.16M2.09M1.87M1.98M2.14M2.07M2.16M2.31M2.41M1.10M1.36M1.45M1.77M1.89M1.42M1.33M1.79M1.59M1.65M
Shareholder's Equity
Total Debt (Quarter)
0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M
Common Equity (Quarter)
14.99M13.16M10.78M9.07M13.33M10.20M7.20M4.50M6.93M5.20M5.66M3.70M8.99M6.60M2.56M1.75M1.47M0.17M2.26M1.79M
Shareholder's Equity (Quarter)
14.99M13.16M10.78M9.07M13.33M10.20M7.20M4.50M6.93M5.20M5.66M3.70M8.99M6.60M2.56M1.75M1.47M0.17M2.26M1.79M
Liabilities and Shareholders Equity (Quarter)
17.24M15.31M12.87M10.94M15.31M12.34M9.27M6.65M9.24M7.60M6.75M5.06M10.44M8.38M4.45M3.17M2.81M1.96M3.85M3.44M
Retained Earnings (Quarter)
-62.93M-65.59M-68.69M-71.55M-75.14M-78.58M-81.87M-84.81M-87.37M-90.47M-91.93M-94.71M-96.94M-99.29M-103.44M-104.47M-105.70M-107.30M-110.47M-111.78M
Preferred Shares (Quarter)
1.001.001.001.001.00
Treasury Shares (Quarter)
2.44M0.12M2.44M